News Medical on MSN17h
Driving the CAR to fight acute myeloid leukemiaA multi-institutional team led by The University of Osaka developed a chimeric antigen receptor (CAR) T cell-based strategy ...
4monon MSN
More information: Rebekka Wegmann et al, Single-cell landscape of innate and acquired drug resistance in acute myeloid ...
Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave ...
Monzr M. Al Malki, MD, discussed data for AlloHeme, a blood test used to detect risk of relapse post-transplant in patients ...
A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified a promising new drug target for acute myeloid leukemia (AML), a deadly ...
Hosted on MSN5mon
Failure in a CAR T cell trial could unlock multiple treatments for acute myeloid leukemiabe able to identify and kill cancer cells with the targeted antigen on their surfaces throughout the body. AML is aggressive, and there are few effective treatment options for relapsed or ...
and cell death. Abnormalities in tyrosine kinases are common in AML, and constitute an attractive therapeutic target. An example is given by the balanced chromosomal translocations (TEL-Abl ...
Acute myeloid leukemia (AML) is one of the most aggressive and genetically complex cancers, marked by the unchecked growth of immature myeloid cells. Its diversity stems from numerous genetic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback